Unknown NA INTERVENTIONAL 2-arm NCT02826616

Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial Infarction

Chinese People's Liberation Army General Hospital

Sponsor: Chinese PLA General Hospital

Updated 6 times since 2017 Last updated: Jul 5, 2016 Started: Jul 31, 2016 Primary completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiovascular Diseases, this trial is ongoing. The trial is conducted by Chinese PLA General Hospital and has accumulated 6 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Aug 2018 — Jan 2021 [monthly]

Unknown Status NA

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Aug 2018 [monthly]

Enrolling By Invitation NA

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese PLA General Hospital

Data source: Chinese PLA General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China